Biotech

All Articles

Former Seagen chief executive officer reveals new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer last year f...

Ironwood makes additional purpose $1B GI medicine along with new subgroup information

.On the heels of a stage 3 win that neglected to wow capitalists, Ironwood Pharmaceuticals is actual...

Novartis inks $150M offer for autoimmune molecular adhesive

.Don't cease Monte Rosa Therapies right now. The Boston-based biotech is actually having a ball afte...

Jade carves out director crew with Chinook veterinarians-- Chutes &amp Ladders

.Invite to this week's Chutes &amp Ladders, our summary of considerable leadership hirings, firings ...

Septerna goes public along with upsized offering of $288M

.Celebrating his company's upsized going public (IPO), Septerna chief executive officer Jeffrey Fine...

AbbVie brings in Richter wealthier, spending $25M to make up invention contract

.AbbVie has actually returned to the resource of its antipsychotic goliath Vraylar seeking another b...

GenSight goes into final full weeks of cash runway as profits flow slips by of grasp

.GenSight Biologics is weeks out of losing amount of money. Once again. The biotech just possesses e...

AZ licenses thrown out uncommon condition drug to Monopar Therapeutics

.Monopar Therapeutics is actually bouncing back a drug from the scrap heap of AstraZeneca's rare ail...

Arcus' new HIF-2a information in renal cancer cells mention potential upper hand over Merck's Welireg, experts say

.Along with brand-new data out on Arcus Biosciences' speculative HIF-2a inhibitor, one team of exper...

Roche bets as much as $1B to extend Dyno gene treatment shipment deal

.After creating a genetics treatment relationship with Dyno Therapeutics in 2020, Roche is actually ...